Feb 23, 2023 / 01:00PM GMT
Operator
Good morning, and welcome to Agios Fourth Quarter and Year-end 2022 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request. I would now like to turn the call over to Jessica Rennekamp, Senior Director of Corporate Communications. Please go ahead.
Jessica Rennekamp - Agios Pharmaceuticals, Inc. - Director of Corporate Communications
Thank you, Operator. Good morning, everyone, and welcome to Agios Fourth Quarter and Year-end 2022 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com. With me on the call today with prepared remarks are Brian Goff, our Chief Executive Officer; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; Tsveta Milanova, our Chief Commercial Officer; and Cecilia Jones, our Chief Financial Officer.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ
Q4 2022 Agios Pharmaceuticals Inc Earnings Call Transcript
Feb 23, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers